Ancora Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,331
Closed -$73K 2064
2022
Q2
$73K Hold
3,331
﹤0.01% 1059
2022
Q1
$61K Hold
3,331
﹤0.01% 1166
2021
Q4
$59K Hold
3,331
﹤0.01% 1185
2021
Q3
$57K Hold
3,331
﹤0.01% 1145
2021
Q2
$56K Hold
3,331
﹤0.01% 1063
2021
Q1
$57K Hold
3,331
﹤0.01% 1017
2020
Q4
$64K Buy
3,331
+923
+38% +$19.3K ﹤0.01% 831
2020
Q3
$57K Buy
+2,408
New +$57.7K ﹤0.01% 822

Other funds holding BTAL

Ancora Advisors's BTAL Position: Q3 2022 in Review

Ancora Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2022, closing a stake of 3,331 shares — an estimated $73K sold.

Ancora Advisors first reported a position in BTAL in Q3 2020 and held it in 8 quarters. The position peaked at $73K in Q2 2022. 63 funds tracked by Wall St. Rank hold BTAL as of Q3 2022.

  • Ancora Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2022 after selling out during the quarter.
  • Ancora Advisors sold 3,331 AGF US Market Neutral Anti-Beta Fund shares in Q3 2022, an estimated $73K.
  • Ancora Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2020 and held it in 8 quarters.
  • Ancora Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $73K in Q2 2022.
  • 63 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2022.

Based on Ancora Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.